MiR-509-3p promotes gastric cancer development by activating FOXM1-mediated p38/MK2 pathway
2024

MiR-509-3p and its Role in Gastric Cancer Development

Sample size: 10 publication 10 minutes Evidence: moderate

Author Information

Author(s): Jiang Nan, Kang Jiawei, Ding Yi, Shataer Munire, Ma Liangying, Tuersong Tayier

Primary Institution: Xinjiang Medical University

Hypothesis

MiR-509-3p and the p38/MK2 pathway are involved in the malignant progression of gastric cancer.

Conclusion

MiR-509-3p suppresses gastric cancer malignant progression by regulating FOXM1-mediated p38/MK2 pathway activation.

Supporting Evidence

  • Overexpression of miR-509-3p suppressed proliferation, migration, and invasion of gastric cancer cells.
  • Knockdown of miR-509-3p promoted malignant progression of gastric cancer.
  • FOXM1 was identified as a target of miR-509-3p, confirming its role in gastric cancer.
  • miR-509-3p overexpression reduced tumor size and weight in vivo.
  • miR-509-3p increased apoptosis in gastric cancer cells.

Takeaway

MiR-509-3p helps stop stomach cancer from getting worse by blocking a specific pathway in the cells.

Methodology

The study used various assays including CCK-8, EdU, Transwell, and Western blot analysis to assess the effects of miR-509-3p on gastric cancer cells.

Limitations

The effectiveness of miR-509-3p in clinical applications needs further evaluation.

Participant Demographics

The study involved human gastric cancer cell lines and nude mice.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.17305/bb.2024.11104

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication